Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Orazio Amabile

Thoracic Surgery (Cardiothoracic Vascular Surgery) Phoenix, AZ Medical Doctor

NPI 1992993927 CMS profile 181451

3131 E Clarendon Ave, 102, Phoenix, AZ 85016

Open in the dashboard

General payments

$19,739

316 records reported · program years 2019–2025

Research payments

$1,374

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Orazio Amabile of Phoenix, AZ is reported in the CMS Open Payments database as having received $19,739 across 316 general payments and $1,374 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,546 58
2024 General $4,257 68
2023 General $3,987 55
2022 General $2,081 34
2021 General $2,542 39
2021 Research $1,374 5
2020 General $1,170 21
2019 General $2,156 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Orazio Amabile
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Orazio Amabile were reported at $3,546. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Orazio Amabile Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $2,156 $886 $178–$3,167 $163
2020 $1,170 $341 $108–$1,605 $114
2021 $2,542 $453 $125–$1,886 $132
2022 $2,081 $695 $180–$2,566 $149
2023 $3,987 $745 $205–$2,662 $160
2024 $4,257 $799 $214–$2,967 $164
2025 $3,546 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $4,276 72 payments
  2. Abbott Laboratories $3,932 69 payments
  3. Bolton Medical Inc $2,102 28 payments
  4. Abiomed $1,618 26 payments
  5. Medtronic, Inc. $1,443 25 payments
  6. CVRx, Inc. $1,223 12 payments
  7. Atricure, Inc. $1,118 20 payments
  8. CryoLife, Inc. $999 10 payments
  9. Medtronic Vascular, Inc. $673 13 payments
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $515 4 payments
  11. Other $1,839 37 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $19,696 315 payments
  2. Education $43 1 payment
Products named General payments · program years 2019–2025
  1. EPIC $1,487 23 payments
  2. Barostim Neo System $1,223 12 payments
  3. Impella $1,193 21 payments
  4. MITRIS RESILIA Mitral Valve $1,107 10 payments
  5. BIOGLUE SURGICAL ADHESIVE $799 9 payments
  6. AMDS-Ascyrus Medical $774 7 payments
  7. CRYOVALVE SG PULMONARY HUMAN HEART VALVE $755 5 payments
  8. Avalus $749 11 payments
  9. ATRICLIP LAA EXCLUSION SYSTEM $705 8 payments
  10. ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER $624 7 payments
  11. Other $11,423 195 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Carmat $1,374 5 payments

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$147,508

Medicare's payments for the services billed

Medicare patients

143

Average age 73

Services billed

320

57 women, 86 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 72%
Heart failure 51%
Atrial fibrillation 51%
Chronic kidney disease 42%
Arthritis 41%
Diabetes 39%
COPD 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

321 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record